To evaluate the efficacy of cutis capsule and cutis oil in Atopic Eczema
Phase 2
- Conditions
- Health Condition 1: null- Suffering from atopic eczema with EASI score 15
- Registration Number
- CTRI/2017/11/010570
- Lead Sponsor
- Vasu Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Non pregnant,non lactating females
2. Patient with atopic eczema according to Rajka and Hanifin criteria
3. Patient with EASI score 15 at time of screening
Exclusion Criteria
1. Pregnant,lactating mother
2. Patient with infected atopic eczema
3. Patient with severe systemic disorder
4. Patient with known hypersensitivity to excipients of drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in the eczematic area and skin moisture level at end of study  <br/ ><br>Timepoint: 0 day and 56th Day of the study <br/ ><br>
- Secondary Outcome Measures
Name Time Method EASI score, SCORAD score,DLQI score at starting and at end of studyTimepoint: at 14 days,28 days,after 56 days <br/ ><br>